Detail akcie Isracann Bioscie Rg online

Business Summary: Isracann Biosciences Inc. is a Canada-based cannabis company. The principal business focus of the Company is medical cannabis cultivation and distribution to provide products to the Israeli medical cannabis market, and to develop and validate Natural Health Products (NHP), through the Company’s operating subsidiaries. The Company's segments include Head Office, Medical Cannabis and Natural Health Product. The Company aims to commercialize natural health medicines in Canada and to leverage agreements within Israel for import/export opportunities and medicinal marijuana cultivation. The Company's subsidiaries include Isracann Holdings Inc., Praesidio Health Inc., Isracann Biosciences Capital Ltd., Isracann Operations Ltd., Isracann Development Ltd., Isracann Agritech Ltd., Isracann Administrative Services Ltd. and others.
Financial Summary: BRIEF: For the three months ended 31 August 2022, Isracann Biosciences Inc revenues was not reported. Net loss decreased 33% to C$316K. Lower net loss reflects Office facilities and administrative decrease of 87% to C$12K (expense), Consulting decrease of 27% to C$161K (expense), Promotion and advertising decrease from C$33K (expense) to C$0K.